Keith W Pratz
ECOG-ACRIN Cancer Research Group · JHU Sidney Kimmel Comprehensive Cancer Center LAO · Johns Hopkins University/Sidney Kimmel Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Keith W Pratz as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:28 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07862517 · Testing the Investigational Medication Combination of Azacitidine, Venetoclax, and Quizartinib Compared to the Usual Treatment of Cytarabine, Daunorubicin, and Quizartinib for Patients With FLT3-ITD Mutant Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)National Cancer Institute (NCI) · not yet recruiting · Acute Myeloid Leukemia · principal investigator
- Ph2NCT03289910 · Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic LeukemiaNational Cancer Institute (NCI) · active not recruiting · Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid Leukemia · principal investigator
- Ph1NCT00588991 · Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersNational Cancer Institute (NCI) · completed · Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:28 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ECOG-ACRIN Network Group Operations CenterU10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · fiscal years 2016 to 2026Named on NCT07862517
- The Johns Hopkins Translational Science Team and Consortium for ETCTN StudiesUM1CA186691 · NCI · JOHNS HOPKINS UNIVERSITY · PI Jan Hendrik Beumer, Michael A Carducci, Ryan Gentzler, GLENN LIU, Wells A. Messersmith, Jimmy Ruiz · fiscal years 2016 to 2026Named on NCT03289910, NCT00588991
- Cancer Chemical and Structural BiologyP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI James M. Berger · fiscal years 2015 to 2026Named on NCT00588991
- U01CA062491RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00588991
- U01CA069912RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00588991
- U01CA070095RePORTER returned no project for this number; it is shown as the registry gives it.Named on NCT00588991
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.